{"@id":"https://bioecon.ru/technology/antigen-coupled-red-blood-cells-for-tolerance/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/antigen-coupled-red-blood-cells-for-tolerance/","json":"https://cn.bioecon.ru/api/v1/technology/antigen-coupled-red-blood-cells-for-tolerance/index.json"},"id":"antigen-coupled-red-blood-cells-for-tolerance","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/loopworm/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/phytolon/","https://bioecon.ru/companies/esco-aster/"]},"maturity":7,"name":"抗原偶联红细胞诱导特异性免疫耐受技术","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"自体红细胞单采与膜表面温和活化"},{"n":2,"title":"致病性髓鞘/凝血因子抗原多肽偶联"},{"n":3,"title":"脾脏边际区耐受型巨噬细胞生理吞噬"},{"n":4,"title":"抗原特异性诱导Treg持久免疫耐受确证"}],"summary":"通过温和生物正交偶联将特异性自身抗原或重组蛋白短肽共价固定于自体成熟红细胞表面，利用衰老红细胞在脾脏与肝脏生理性自然清除机制，诱发强大的抗原特异性Treg免疫耐受，彻底克服多发性硬化与血友病抗体中和难题。","url":"/technology/antigen-coupled-red-blood-cells-for-tolerance/","verified":"2026-11-22"}